Frequent allelic losses of 9p21 markers and low incidence of mutations at p16(CDKN2) gene in non-Hodgkin lymphomas of B-cell lineage
- PMID: 9309120
- DOI: 10.1016/s0165-4608(96)00400-1
Frequent allelic losses of 9p21 markers and low incidence of mutations at p16(CDKN2) gene in non-Hodgkin lymphomas of B-cell lineage
Abstract
We present an allelotype analysis of 35 cases of non-Hodgkin lymphomas and normal pairs using four microsatellite markers that flank the region occupied by the CDKN2 gene locus at 9p21. Frequent allelic losses (LOH) were detected in B-cell lineage NHLs, including Burkitt lymphoma (33.3% of total, if we only consider high grade tumors). In five of these tumors LOH did not include the CDKN2 gene. Mutational analysis of exon 1 and 2 of CDKN2 (SSGP and sequencing of abnormal bands) revealed a nonsense mutation (Arg72Ter) in one tumor (case 10), where the second hit of the Knudson's model consisted of the elimination of the wild type allele. In view of these results, the hypothesis of two different candidate tumor suppressor gene regions around the CDKN2 locus remains an intriguing possibility.
Similar articles
-
Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma.Int J Cancer. 1996 Mar 15;65(6):762-7. doi: 10.1002/(SICI)1097-0215(19960315)65:6<762::AID-IJC9>3.0.CO;2-X. Int J Cancer. 1996. PMID: 8631588
-
Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells.Cancer Res. 1995 Jul 1;55(13):2892-5. Cancer Res. 1995. PMID: 7796417
-
Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus.Oncogene. 1996 Nov 7;13(9):1867-73. Oncogene. 1996. PMID: 8934532
-
Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.Genes Chromosomes Cancer. 1996 Feb;15(2):77-88. doi: 10.1002/(SICI)1098-2264(199602)15:2<77::AID-GCC1>3.0.CO;2-0. Genes Chromosomes Cancer. 1996. PMID: 8834170 Review.
-
CDKN2 (MTS1/p16INK4A) gene alterations in hematological malignancies.Leuk Lymphoma. 1997 Feb;24(5-6):449-61. doi: 10.3109/10428199709055583. Leuk Lymphoma. 1997. PMID: 9086436 Review.
Cited by
-
p53 and p16INK4A mutations during the progression of glomus tumor.Pathol Oncol Res. 1999;5(1):41-5. doi: 10.1053/paor.1999.0041. Pathol Oncol Res. 1999. PMID: 10079377
-
Microsatellite instability and k-ras, p53 mutations in thyroid lymphoma.Jpn J Cancer Res. 2000 Mar;91(3):280-6. doi: 10.1111/j.1349-7006.2000.tb00942.x. Jpn J Cancer Res. 2000. PMID: 10760686 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous